4.2 Article

Balancing enrollment and mortality in hemorrhage control trials: A secondary analysis of the PROPPR trial

Related references

Note: Only part of the references are listed.
Article Surgery

A Decade of Damage Control Resuscitation New Transfusion Practice, New Survivors, New Directions

Elaine Cole et al.

Summary: Recent innovations in trauma major hemorrhage management have led to a significant decrease in mortality rates, although there are still opportunities for improvement. The proportion of trauma patients dying within a short period has decreased, with survivors more likely to be discharged home. Late deaths are now mainly attributed to traumatic brain injury and multiple organ dysfunction.

ANNALS OF SURGERY (2021)

Review Surgery

Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma Trials

John B. Holcomb et al.

Summary: The study aims to develop consensus-based recommendations for primary clinical outcomes for pivotal trials in patients suffering from significant bleeding, including traumatic injury, intracranial hemorrhage, and other 6 categories. Standardized primary outcomes in clinical trials evaluating hemostatic products will facilitate research, interpretation, and translation into clinical practice.

ANNALS OF SURGERY (2021)

Review Hematology

Trauma-induced coagulopathy: The past, present, and future

Lucy Z. Kornblith et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

Article Critical Care Medicine

Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: Design, rationale and implementation

Sarah Baraniuk et al.

INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2014)